HomeMCPWorkbenchSkills
HomeWorkbenchNotificationsMe
Huagongshe Open Program:[email protected]AI access: llms.txt · MCP GuidePrivacy Policy · Terms of Service · Supportv1.7.8
  1. Home
  2. /Compound

Fluphenazine Enanthate

HCID 3389
NotesReactions
Basic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes
Substructure searchFind similar structures

Basic information

CAS
2746-81-8
Standard SMILES
CCCCCCC(=O)OCCN1CCN(CCCN2c3ccccc3Sc3ccc(C(F)(F)F)cc32)CC1
InChIKey
LRWSFOSWNAQHHW-UHFFFAOYSA-N
Molecular formula
C29H38F3N3O2S
Average molar mass
549.7 g/mol
Monoisotopic mass
549.26368312

Overview

Fluphenazine enanthate is a member of phenothiazines.

Names & identifiers

Preferred name
Fluphenazine Enanthate
IUPAC
2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl heptanoate
English name
fluphenazine O-enantate
Molecular formula
C29H38F3N3O2S
Molecular weight
549.698

Names & synonyms

fluphenazine enanthate2746-81-8Prolixin EnanthateFluphenazine enantateFlufenanSQ 16,114QSB34YF0W9Fluphenazini enantasDTXSID6023070SQ 161442-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl heptanoate2-(4-(3-(2-(trifluoromethyl)-10H-phenothiazin-10-yl)propyl)piperazin-1-yl)ethyl heptanoate
Show more names
fluphenazine O-enantateFluphenazine enantate CRSFLUPHENAZINE ENANTHATE (LIQ)Fluphenazine Decanoate Impurity 3 (Fluphenazine Decanoate EP Impurity C)2-[4-[3-[2-(Trifluoromethyl)phenothiazin-10-yl]propyl]-1-piperazinyl]ethyl heptanoateenanthic acid 2-[4-[3-[2-(trifluoromethyl)phenothiazin-10-yl]propyl]piperazin-1-yl]ethyl esterHeptanoic acid, 2-4-3-2-(trifluoromethyl)-10H-phenothiazin-10-ylpropyl-1-piperazinylethyl ester
2-(4-{3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl}piperazin-1-yl)ethyl heptanoateModiten enant2-(4-(3-(2-(trifluoromethyl)phenothiazin-10-yl)propyl)piperazin-1-yl)ethyl heptanoateRefChem:55216DTXCID403070EutimoxModiten enanthateModiten-retard

Database identifiers

CAS
2746-81-8
PubChem CID
3389
DTXSID
DTXSID6023070
ChEMBL
CHEMBL1200951
ChEBI
CHEBI:5125
UNII
QSB34YF0W9
EC Number
220-385-0
Nikkaji
J7.903K

Properties

Computed structural properties

XLogP
7.4
Topological polar surface area
61.3 Ų
Hydrogen bond donors
0
Hydrogen bond acceptors
9
Rotatable bonds
13
Heavy atoms
38
Formal charge
0
Complexity
720

Experimental & physicochemical properties

Human Drugs · 2 items

FDA approved drugs -> Active ingredient

FDA approved drugs -> Active ingredient

Physicochemical properties

Melting point
184.5 °C · 184.5°C
Boiling point
629.4 · 629.4±55.0 °C(Predicted)
Density
1.1661 · 1.1661 (estimate)
storage temp.
2 · 2-8°C
solubility
Practically insoluble in water, very soluble in ethanol and in methylene chloride, freely soluble in methanol.
pka
7.32 · 7.32±0.10(Predicted)
Major Application
pharmaceutical (small molecule)
InChIKey
LRWSFOSWNAQHHW-UHFFFAOYSA-N
SMILES
FC(F)(F)c1cc2c(cc1)Sc3c(cccc3)N2CCCN4CCN(CC4)CCOC(=O)CCCCCC
FDA UNII
34 YF0W9 · QSB34YF0W9
UNSPSC Code
41116107 · 41116107
NACRES
24 · NA.24
Symbol(GHS)
6 · GHS06,GHS08
Signal word
Danger
Hazard statements
301 · H301-H360
Precautionary statements
201 · P201-P301+P310+P330
RIDADR
3249 · 3249
WGK Germany
3 · WGK 3
HazardClass
6.1 · 6.1(b)
PackingGroup
III
Storage Class
6.1 C · 6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
Hazard Classifications
3 OralRepr · Acute Tox. 3 OralRepr. 1A

Safety & regulation

Safety information is for reference only and does not replace the supplier’s Safety Data Sheet (SDS), applicable regulations, or professional assessment.

GHS classification

GHS Classification · 4 items

Danger

H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]

P233, P260, P261, P264, P270, P271, P272, P280, P284, P301+P317, P302+P352, P304+P340, P317, P321, P330, P333+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 17 reports by companies from 1 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

Hazard information

Regulatory Information · 2 items

Hazard Traits - Bioaccumulation; Environmental Persistence

Heptanoic acid, 2-4-3-2-(trifluoromethyl)-10H-phenothiazin-10-ylpropyl-1-piperazinylethyl ester: Does not have an individual approval but may be used under an appropriate group standard

Other Safety InformationIMAP assessments - Heptanoic acid, 2-[4-[3-[2-(trifluoromethyl)-10H-phenothiazin-10-yl]propyl]-1-piperazinyl]ethyl ester: Environment tier I assessment
Hazard Classes and CategoriesAcute Tox. 4 (100%)

Safety data

wgk
WGK 3
ridadr
3249
Signal word
Danger
Symbol(GHS)
GHS06,GHS08
hazard_class
6.1(b)
Storage Class
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects
packing_group
III
Hazard statements
H301-H360
Hazard Classifications
Acute Tox. 3 OralRepr. 1A
Precautionary statements
P201-P301+P310+P330

Chemistry & industry

Pharmacology

MeSH Pharmacological Classification · 1 item

Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus.

Applications · 2 items

UsesFluphenazine Enanthate serves as a medication for the treatment of tardive dyskinesia (TD) in monkeys. Fluphenazine Enanthate also functions as a medication for the antipsychotics study on human prolactin levels. Fluphenazine Enanthate reduces the blood pressure of pentobarbital Na anesthetized dogs, reduces heart rate in anesthetized dogs, and increases coronary blood flow and femoral blood flow in anesthetized dogs enhancing cardiovascular functions.

UsesAntipsychotic.

Suppliers18 total

孟成科技(上海)有限公司400-820-6829 · [email protected]
广州爱纯医药科技有限公司020-39119399 18927568969 · [email protected]
天津普西唐生物医药科技有限公司010-60605840 · [email protected]
陕西缔都医药化工有限公司029-81024372 17792795018 · [email protected]
青岛海智微元生物科技有限公司18317699790 18317699790 · [email protected]
TLC梯尔希(南京)药物研发有限公司18012923235 · [email protected]
珠海安哲生物科技有限公司13169972583 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354; +1-00000000000 · [email protected]
BOC Sciences16314854226; +8616314854226 · [email protected]
BOC Sciences16314854226 · [email protected]
上海源叶生物科技有限公司18916372613 · [email protected]
上海陶术生物科技股份有限公司13564774135 · [email protected]
成都标样生物科技有限公司028-81700200 13308200041 · [email protected]
上海立崎生物医学研究中心18014399201 · [email protected]
TargetMol中国(陶术生物)4008200310 15002144251 · [email protected]
DAYANG CHEM (HANGZHOU) CO.,LTD+86-88938639 +86-17705817739 · [email protected]
上海陶术生物科技股份有限公司+1-781-999-5354 · [email protected]
湖北清北云研医药科技有限责任公司18162595016; 18162595016 · [email protected]

Additional notes

DefinitionChEBI: Fluphenazine enanthate is a member of phenothiazines.

Related reactions

0 records
New reaction record

No reaction records under the current filter.

Compound notes

Loading…

On this pageBasic informationOverviewNames & identifiersPropertiesSafety & regulationChemistry & industryRelated reactionsCompound notes